Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273858
Status:
TERMINATED
Last Update Posted:
2011-09-12
First Post:
2006-01-04
Brief Title:
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis Ankylosing Spondylitis and Psoriatic Arthritis
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
Open Label Study To Evaluate The Safety Profile And The Quality Of Life In Patients Receiving Etanercept For The Treatment Of Rheumatoid Arthritis Ankylosing Spondylitis And Psoriatic Arthritis
Status:
TERMINATED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was terminated because at least one year follow-up was achieved for each patient and the achievement of 965 exposure years to the drug
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 4 open label non-interventional multi-center study to evaluate the safety of Enbrel etanercept treatment in patients receiving etanercept 25mg sc twice weekly or 50mg of etanercept once weekly The improvement of health-related quality of life will also be evaluated
Detailed Description:
Patients already prescribed to receive etanercept for the first time for treatment of Rheumatoid Arthritis Ankylosing Spondylitis or Psoriatic Arthritis according to the Summary of Product Characteristics SmPC
Patients have been recruited sequentially based on eligibility criteria up to the number limit assigned to each site
Patients have been recruited sequentially based on eligibility criteria up to the number limit assigned to each site
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B1801106 | None | None | None |